Management of Duchenne Muscular Dystrophy
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease
2
FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy
3
Advancing DM1 and DMD Care: Insights on DYNE-101 and DYNE-251 Development
4
Evaluating GLP-1 Receptor Agonist Semaglutide in Phase 3 Settings for Alzheimer Disease: The EVOKE Trials
5
